CAH Relative Valuation
CAH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CAH is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for CAH's competitors is 0.75, providing a benchmark for relative valuation. Cardinal Health Inc Corp (CAH) exhibits a P/S ratio of 0.15, which is -80.02% above the industry average. Given its robust revenue growth of 0.02%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Cardinal Health Inc (CAH) currently overvalued or undervalued?
What is Cardinal Health Inc (CAH) fair value?
How does CAH's valuation metrics compare to the industry average?
What is the current P/B ratio for Cardinal Health Inc (CAH) as of May 19 2025?
What is the current FCF Yield for Cardinal Health Inc (CAH) as of May 19 2025?
What is the current Forward P/E ratio for Cardinal Health Inc (CAH) as of May 19 2025?